ArticleClinical oral investigations2026
In situ formation of Ca-Ag hybrid nanoparticles for multifunctional reconstruction of the resin-dentin interface.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesThe hybrid layer formed during dentin bonding remains susceptible to degradation. This study aimed to develop a CaCl₂/AgF treatment strategy for in situ deposition of Ca-Ag hybrid nanoparticles within the demineralized dentin matrix (DDM) and to evaluate its effects on interface-confined water regulation, antibiofilm activity, mineral deposition, and ultimately bonding durability. MATERIALS AND
methodsDDM was sequentially treated with CaCl₂ and AgF solutions. Interface-confined water regulation was assessed by surface potential, water uptake, and thermogravimetric analysis (TGA). Antibiofilm activity against Streptococcus mutans (S. mutans) and saliva-derived microcosm biofilms was evaluated by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). Mineral deposition was examined by transmission electron microscopy (TEM) and selected area electron diffraction (SAED). Adhesive infiltration, nanoleakage, and microtensile bond strength (1 day and 12 months) were tested.
resultsCa-Ag deposition was associated with reduced interfacial hydration, as indicated by reduced surface potential, decreased water uptake, and lower mass loss below 200 °C in TGA. It inhibited biofilm formation and disrupted established biofilms. Enhanced mineral deposition occurred within 1 h in the Ca-Ag group, with SAED patterns showing crystalline mineral phases, whereas controls remained unmineralized. Enhanced adhesive infiltration, reduced nanoleakage, and improved 12-month bond strength were observed.
conclusionsSequential CaCl₂/AgF treatment induced the in situ deposition of Ca-Ag hybrid nanoparticles within the DDM, which was associated with reduced interfacial hydration, antibiofilm activity, mineral deposition, and improved bonding performance in vitro. CLINICAL SIGNIFICANCE: This in vitro study suggests that CaCl₂/AgF treatment may represent a potential strategy for improving resin-dentin interface stability. Further investigations are required to evaluate its clinical applicability.
Indexed as
Identifiers
42593557What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.